Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning

Author:

Ito Takanori1ORCID,Morooka Hikaru2,Takahashi Hirokazu3ORCID,Fujii Hideki4,Iwaki Michihiro5,Hayashi Hideki6,Toyoda Hidenori7ORCID,Oeda Satoshi38,Hyogo Hideyuki910,Kawanaka Miwa11,Morishita Asahiro12ORCID,Munekage Kensuke13,Kawata Kazuhito14,Tsutsumi Tsubasa15ORCID,Sawada Koji16ORCID,Maeshiro Tatsuji17,Tobita Hiroshi18ORCID,Yoshida Yuichi19,Naito Masafumi19,Araki Asuka18,Arakaki Shingo17,Kawaguchi Takumi15ORCID,Noritake Hidenao14,Ono Masafumi20,Masaki Tsutomu12,Yasuda Satoshi7,Tomita Eiichi6,Yoneda Masato5,Tokushige Akihiro21,Ishigami Masatoshi1ORCID,Kamada Yoshihiro22,Ueda Shinichiro23,Aishima Shinichi24,Sumida Yoshio25ORCID,Nakajima Atsushi5ORCID,Okanoue Takeshi26,

Affiliation:

1. Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine Nagoya Japan

2. Department of Emergency and Critical Care Medicine Nagoya University Graduate School of Medicine Nagoya Japan

3. Liver Center Saga University Hospital Saga Japan

4. Department of Hepatology, Graduate School of Medicine Osaka Metropolitan University Osaka Japan

5. Division of Gastroenterology and Hepatology Yokohama City University Graduate School of Medicine Yokohama Japan

6. Department of Gastroenterology and Hepatology Gifu Municipal Hospital Gifu Japan

7. Department of Gastroenterology Ogaki Municipal Hospital Ogaki Japan

8. Department of Laboratory Medicine Saga University Hospital Saga Japan

9. Department of Gastroenterology JA Hiroshima Kouseiren General Hospital Hiroshima Japan

10. Hyogo Life Care Clinic Hiroshima Hiroshima Japan

11. Department of General Internal Medicine 2, Kawasaki Medical Center Kawasaki Medical School Okayama Japan

12. Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Takamatsu Japan

13. Department of Gastroenterology and Hepatology Kochi Medical School Kochi Japan

14. Hepatology Division, Department of Internal Medicine II Hamamatsu University School of Medicine Shizuoka Japan

15. Division of Gastroenterology, Department of Medicine Kurume University School of Medicine Kurume Japan

16. Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology Asahikawa Medical University Asahikawa Japan

17. First Department of Internal Medicine University of the Ryukyus Hospital Okinawa Japan

18. Division of Hepatology Shimane University Hospital Izumo Japan

19. Department of Gastroenterology and Hepatology Suita Municipal Hospital Osaka Japan

20. Division of Innovative Medicine for Hepatobiliary and Pancreatology, Faculty of Medicine Kagawa University Takamatsu Japan

21. Department of Cardiovascular Medicine and Hypertension Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan

22. Department of Advanced Metabolic Hepatology Osaka University Graduate School of Medicine Osaka Japan

23. Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine University of the Ryukyus Okinawa Japan

24. Department of Pathology and Microbiology, Faculty of Medicine Saga University Saga Japan

25. Division of Hepatology and Pancreatology, Department of Internal Medicine Aichi Medical University Nagakute Japan

26. Hepatology Center Saiseikai Suita Hospital Suita Japan

Abstract

AbstractBackground and AimsBoth fibrosis status and body weight are important for assessing prognosis in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to identify population clusters for specific clinical outcomes based on fibrosis‐4 (FIB‐4) index and body mass index (BMI) using an unsupervised machine learning method.MethodsWe conducted a multicenter study of 1335 biopsy‐proven NAFLD patients from Japan. Using the Gaussian mixture model to divide the cohort into clusters based on FIB‐4 index and BMI, we investigated prognosis for these clusters.ResultsThe cohort consisted of 223 cases (16.0%) with advanced fibrosis (F3–4) as assessed from liver biopsy. Median values of BMI and FIB‐4 index were 27.3 kg/m2 and 1.67. The patients were divided into four clusters by Bayesian information criterion, and all‐cause mortality was highest in cluster d, followed by cluster b (P = 0.001). Regarding the characteristics of each cluster, clusters d and b presented a high FIB‐4 index (median 5.23 and 2.23), cluster a presented the lowest FIB‐4 index (median 0.78), and cluster c was associated with moderate FIB‐4 level (median 1.30) and highest BMI (median 34.3 kg/m2). Clusters a and c had lower mortality rates than clusters b and d. However, all‐cause of death in clusters a and c was unrelated to liver disease.ConclusionsOur clustering approach found that the FIB‐4 index is an important predictor of mortality in NAFLD patients regardless of BMI. Additionally, non‐liver‐related diseases were identified as the causes of death in NAFLD patients with low FIB‐4 index.

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3